Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Mammograms are important for detecting breast cancer early.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Garlic may help reduce side effects of breast cancer treatments.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.